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Pasteurella multocida Toxin
Manipulates T Cell Differentiation
Dagmar Hildebrand, Klaus Heeg and Katharina F. Kubatzky*
Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Heidelberg, Heidelberg, Germany
Pasteurella multocida causes various diseases in a broad range of wild and domestic
animals. Toxigenic strains of the serotypes A and D produce an AB protein toxin
named Pasteurella multocida toxin (PMT). PMT constitutively activates the heterotrimeric
G protein subunits Gαq, Gα13, and Gαi through deamidation of a glutamine residue,
which results in cytoskeletal rearrangements as well as increased proliferation and
survival of the host cell. In human monocytes, PMT alters the lipopolysaccharide
(LPS)-induced activation toward a phenotype that suppresses T cell activation. Here
we describe that the toxin also modulates CD4-positive T helper (Th) cells directly.
PMT amplifies the expansion of Th cells through enhanced cell cycle progression and
suppression of apoptosis and manipulates the differentiation of Th subclasses through
activation of Signal Transducers and Activators of Transcription (STAT) family members
and induction of subtype-specific master transcription factors. A large population of
toxin-treated T cells is double-positive for Foxp3 and RORγt, the transcription factors
expressed by Treg and Th17 cells, respectively. This suggests that these cells could
have the potential to turn into Th17 cells or suppressive Treg cells. However, in terms
of function, the PMT-differentiated cells behave as inflammatory Th17 cells that produce
IL-17 and trigger T cell proliferation.
Keywords: Th17 cells, regulatory T cell, STAT proteins, Pasteurella multocida toxin, T cell proliferation, T helper
cell differentiation, Foxp3, RORγt
INTRODUCTION
An eﬀective T cell-driven immune response against microbial pathogens depends on the T
cell receptor (TCR)-mediated expansion of antigen-speciﬁc T cells as well as the diﬀerentiation
of specialized T cell subsets. The nature of the invading pathogen determines the resulting
CD4-positive Th subtype that is generated. Microbial components are recognized by distinct
pattern recognition receptors (PRRs) on innate immune cells. As a consequence, professional
antigen-presenting cells (APCs) perform phagocytosis and present foreign antigens on major
histocompatibility complexes (MHC) to T cells. Binding of presented antigens to the TCR transmits
the activation signal to intracellular molecules, which trigger cellular proliferation. In addition,
APCs can express T cell-activating surface molecules that bind the co-receptor CD28. This ligand-
receptor binding is required for the full activation and expansion of T cells. Depending on
the activated PRR, APCs produce a speciﬁc set of cytokines that deﬁnes the direction of Th
diﬀerentiation. The released cytokines bind to their responding receptors on the Th cell and induce
signaling cascades that are transmitted through Signal Transducers and Activators of Transcription
(STAT) proteins. Depending on the cytokine STAT-3, STAT-4, STAT-5, or STAT-6 then induce the
expression of Th subtype-speciﬁc master transcription factors. Together with the STAT proteins,
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they ﬁnally determine the diﬀerentiation of eﬀector cells by
triggering gene expression of lineage-characteristic cytokines and
surface molecules (O’Shea et al., 2011). In this way, pathogen-
speciﬁc Th eﬀector cells develop to help provide an immune
response tailored to recognize and destroy the microorganism.
Initially, only two resulting Th subtypes, Th1 and Th2, were
known. While Th1 cells that release IFN-γ and TNF-α, stimulate
innate and T cell-induced immunity to recognize intracellular
bacteria, Th2 cells boost the response against extracellular
pathogens in the humoral andmucosal immunity. Today, a much
higher variety of eﬀector Th cells such as Th3, Th9, TR1, T
follicular helper cells, Th17 and the suppressive regulatory T cells
(Tregs) are known (Zhu and Paul, 2010). They can be seen as
separate types or as a speciﬁc state of a certain main lineage.
The plasticity of T cell diﬀerentiation is remarkable and allows
a quick adaption to the invading microbe. Furthermore, this
plasticity allows the control of the sensitive balance of defense
activation and suppression, which is a prerequisite for a successful
and moderate immune response. Lately it has become clear
that the interplay between Th17 cells and Tregs is particularly
important to maintain homeostasis (Astry et al., 2015; Chen
et al., 2015; Talaat et al., 2015) as these two T cell subtypes
have opposite functions in the regulation of the immune system.
Th17 cells are named after the IL-17 family of cytokines and
activate a broad range of immune cells (Park et al., 2005), hence
Th17 cells are considered potent inﬂammatory cells with a role
in autoimmune disorders (reviewed in (Korn et al., 2009). In
contrast, induced Tregs (iTregs) mediate immune suppression
and protect from an overactive immune response (Shevach and
Thornton, 2014), whereas natural Tregs (nTregs) develop from
autoreactive thymocytes in the medulla of the thymus and
sustain tolerance to self-antigens (Bettini and Vignali, 2010).
The precise division between nTreg and iTreg-mediated modes
of suppression however, is still under investigation (Curotto
de Lafaille and Lafaille, 2009). Although Th17 cells and Tregs
have opposite functions, the diﬀerentiation of both lineages is
closely connected. Th17 cell development is mediated by TGF-β
and IL-6, the activation of STAT-3 and the following induction
of RORγt (Ivanov et al., 2006; Tanaka et al., 2014). Induced
Tregs can be diﬀerentiated from peripheral CD4+CD25− T
cells through activation of the transcription factors STAT-5
and Foxp3 in the presence of TGF-β and IL-2 (Burchill et al.,
2007; Schmitt and Williams, 2013). Thus Th17 diﬀerentiation, as
well as Treg formation, are dependent on TGF-β. In addition,
the transcription factors Foxp3 and RORγt can inﬂuence each
other and generate intermediate T cell subtypes such as IL-17-
releasing Foxp3-positive cells (Voo et al., 2009; Kryczek et al.,
2011). Finally, Th17 cells can turn into iTregs and nTregs can
be converted into Th17 cells, respectively, under inﬂammatory
conditions (Kong et al., 2012). However, this plasticity of CD4-
positive T cells also has disadvantages for the host as it represents
a welcome target for pathogens to modulate the immune
response. T cell diﬀerentiation can either be indirectly modulated
through the manipulation of APCs or directly through induction
of signaling cascades in the lymphocyte (Miethke et al., 1994;
Smith et al., 2004; Ivars, 2007; Sakai et al., 2010; Rodriguez-Garcia
et al., 2011). Pasteurellamultocida toxin (PMT) from P. multocida
manipulates the host’s signaling cascades through constitutive
activation of the alpha subunits of the heterotrimeric G proteins
Gq, G13, and Gi through deamidation of glutamine residue (Orth
and Aktories, 2010). Downstream of the activated G protein,
signaling events such as calcium mobilization, phospholipase C
activation, activation of the small GTPase RhoA or mitogen-
activated protein (MAP) kinase pathways have been reported
(Wilson and Ho, 2011). Furthermore, we could show that PMT
mediates long-term activation of the Janus kinase (JAK)-STAT
pathway through constitutive activation of Gq. This results in
constitutive STAT-3 activation and aberrant expression of its
target gene, the kinase Pim-1 which in turn phosphorylates
and thus inhibits the negative feedback regulator supressor
of cytokine signaling (SOCS)-1 (Orth et al., 2007; Hildebrand
et al., 2010). Eventually this causes an enhanced expression of
JAK2 and an increase in STAT-3 activity. As a consequence
of PMT-induced signaling, the toxin stimulates proliferation of
a variety of cells types such as ﬁbroblasts, bladder epithelial
cells or osteoclasts, and protects cells eﬃciently from apoptosis
(Preuss et al., 2010; Wilson and Ho, 2012). Recently we have
shown that PMT alters the lipopolysaccharide (LPS)-induced
activation of human monocytes toward a phenotype which
shows decreased T cell activation (Hildebrand et al., 2012). The
study presented here aimed to answer the question whether PMT
can also directly modulate CD4-positive T cells responses. Our
experiments on human blood-derived Th cells demonstrate that
the toxin ampliﬁes the CD3/CD28-induced expansion of T cells
through enhanced cell cycle progression and survival. Moreover,
PMT modulates the diﬀerentiation of Th cells into speciﬁc
subtypes. The toxin mediates activation of STAT family members
and the expression of the subtype determining transcription
factors RORγt and Foxp3. Our experiments show that the PMT-
generated T cell phenotype is able to induce proliferation of naïve
T cells as well as the diﬀerentiation of Th17 cells.
MATERIALS AND METHODS
Expression of Recombinant Protein
Recombinant PMT and PMTC1165S were kindly provided by
J. Orth and K. Aktories (Freiburg). The toxin was expressed and
puriﬁed as described before. Possible endotoxin contaminations
were removed by an endotoxin removing gel (Pierce; Hildebrand
et al., 2014).
T Cell Isolation
Peripheral blood mononuclear cells were isolated from fresh
blood or buﬀy coats by density gradient centrifugation (Pancoll
1.077 g/mL; PAN Biotech) and washed three times with PBS.
CD4-positive T cells were negatively selected (untouched) by
magnetic-associated cell sorting (CD4+ T Cell Isolation Kit,
Miltenyi Biotec) and AutoMACS technology twice. Sorted
cells (93–97% purity) were cultured in RPMI 1640 medium
(Biochrom AG) supplemented with 10% FBS and 1% penicillin
and streptomycin (PAA laboratories) at 37◦C in a humidiﬁed
atmosphere in the presence of 5% CO2.
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Activation and Stimulation
Cells were seeded at a concentration of 2.5 million per ml and
activated with anti-CD3 and anti-CD28-coated beads (T Cell
Activation/Expansion Kit, Miltenyi Biotec) at a ratio of 1:2. Cells
were stimulated with PMT, PMTC1165S or heat-inactivated dT
PMT (65◦C, 1 h) at a concentration of 1 nM. Cholera toxin (CT)
and nocodazole (Sigma–Aldrich) were used at 100 ng/ml.
T Cell Differentiation In Vitro
For the in vitro diﬀerentiation of Th17 cells, CD3/CD28-
activated Th cells were stimulated 5–7 days with 100 ng/ml
of recombinant IL-1β, IL-6, IL-23, and TGF-β (Immuno
Tools GmbH). Regulatory T cells were generated by treatment
with 100 ng/ml rapamycin (Calbiochem) and 200 ng/ml IL-2
(Immuno Tools GmbH).
Cell Viability Assay
T cells were stimulated for 5 days in a 96-well plate. Then the
CellTiter-Glo R© Luminescent Cell Viability Assay (Promega) was
performed by following the manufacturer’s protocol. By adding
the CellTiter-Glo reagent, cells are lysed and a luminescent signal
(measured with a microplate reader, Hidex) proportional to the
amount of ATP is generated.
Carboxyfluorescein Succinimidyl Ester
(CFSE) Staining
Isolated T cells were stained with carboxyﬂuorescein
succinimidyl ester (CFSE; 2.5 million cells/ml, 5 μM CFSE,
Biolegend) for 10 min at room temperature (r.t.) in the dark,
before the reaction was stopped with cold medium containing
10% FCS. After washing the cells with medium, they were
activated and stimulated as described above. Fluorescence
intensity of the cells was quantiﬁed with a FACSCanto on day
one (basis measurement) and day ﬁve.
ELISA
Supernatants of cultured T cells were collected at the indicated
time points for the subsequent quantiﬁcation of cytokines. IL-2,
IL-17A, and IL-10 ELISAs (Biolegend) were performed following
the manufacturer’s instructions. Measurements were performed
on a Tecan GENios Pro plate reader and analyzed with Magellan5
software.
Cell Cycle Stage Analysis
T cells were synchronized in G0 phase by culturing them
overnight in the absence of an activation stimulus. Then the cells
(250,000 cells per condition) were activated with anti-CD3/CD28
beads and stimulated with PMT, CT (G0/1 phase), or nocodazole
(G2 phase). After 24 h cells were washed and the cell pellet
was resolved in 70% ethanol and stored on ice for 15 min for
ﬁxation. Washed cells were then resolved in staining-solution
(50 μg/ml propidium iodide, 100 μg/ml RNAse A, 0.02% Tween
20 in PBS)with constant vortexing. After incubation for 40min at
37◦C cells were analyzed with a FACSCanto (x-axis: PE-A, y-axis:
PE-W).
Immunoblot Analysis
Cells were washed twice and lysed as described before
(Hildebrand et al., 2010) in RIPA buﬀer and analyzed by
western blotting. Samples were boiled in Laemmli buﬀer and
separated on a 4–20% gradient polyacrylamide gel (Anamed
GmbH) by SDS-PAGE, transferred to nitrocellulose, and
immunoblotted. To determine STAT activation, antibodies
against p(Y705)STAT-3, p(Y693)STAT-4, STAT-4, p(Y694)STAT-
5, STAT-5, p(Y641)STAT-6, STAT-6, actin, and anti-rabbit
horseradish peroxidase (HRP) from Cell Signaling Technology
and against STAT-3 from Santa Cruz Biotechnology were
used. To determine cell cycle-relevant proteins, nuclear extracts
were produced as described before (Hildebrand et al., 2010).
Antibodies were purchased from Cell Signaling Technology
(anti-CDK6, -CDK4, -cyclin D1, -p27, -cyclin B, p(Y15) CDK1),
Santa Cruz Biotechnology (anti-cyclin E, C-19), and Sigma–
Aldrich (anti-B23). Primary antibodies were used 1:1000, HRP-
coupled secondary antibodies 1:5000.
Caspase 3, 7, and 8 Activity Assay
T cells were seeded in 96-well plates, activated with anti-
CD3/CD28-coated beads and treated for 1 or 5 days with PMT.
Caspase 3, 7, and 8 activities were measured using the Caspase-
3/7Glo and Caspase-8Glo Assay (Promega) in accordance to the
manufacturer’s instructions. Luminescence was measured using
the Plate CHAMELEONTMVmicroplate reader (Hidex).
Reverse Transcriptase-PCR
RNA was extracted from T cells with the “High pure RNA
Isolation Kit” (Roche), following the manufacturers protocol.
Total RNA was quantiﬁed with a NanoDrop and cDNA was
prepared using “Reversed Aid First Strand cDNA Synthesis
Kit” (Fermentas Life Science). The cDNA was then used for
quantitative PCR analysis with the “SYBR Green Rox mix”
(Thermo Scientiﬁc) and sequence-speciﬁc primers: actin, sense,
5′- AGA GCT ACG AGC TGC CTG AC -3′, antisense, 5′- AGC
ACT GTG TTG GCG TAC AG-3′, human FOXP3: sense 5′-
GAA ACA GCA CAT TCC CAG AGT TC-3′, antisense 5′- ATG
GCC CAG CGG ATG AG -3′, human TBET: sense, 5′- AAG
TTT AAT CAG CAC CAG ACA GAG ATG ATC -3′, antisense,
5′- AAC AGA TGT GTA CAT GGA CTC AAA GTT CTC -
3′, human GATA3: sense 5′- GCT GTC TGA AGC CAG GAG
AGC -3′, antisense 5′- ATG CAT CAA ACA ACT GTG GCC
AA -3′, human RORC: sense 5′- CCG CTG AGA GGG CTT
CAC -3′, antisense 5′- TGC AGG AGT AGG CCA CAT TAC
A -3′. The results were analyzed using the Fast Real-Time PCR
System (Applied Biosystems). The mean values of the results
(mean ± SEM; n = 2) were normalized to actin.
FACS Staining
T cells were ﬁxed with 4% paraformaldehyde/PBS at r.t. for
15min. Subsequently, the cells were permeabilized in 0.1%Triton
X-100/PBS for 5 min (r.t.). Afterward, one million cells were
incubated with 2 μg of antibodies against CD4 (Miltenyi Biotec),
RORγt, Foxp3, IL-10, or IL-17 (eBioscience) for 1 h at 4◦C. After
washing three times, cells were incubated for 30 min at 4◦C with
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1 μg of the secondary antibody per one million cells (anti-mouse
FITC or anti-rat PE, eBioscience). The antibody against CD4 was
directly labeled with an APCﬂuorophore. Washed cells were then
analyzed on a FACSCanto.
Co-culture Experiment
Isolated, CD3/CD28-activated T cells were diﬀerentiated into
Th17 cells or Tregs or stimulated with PMT for 7 days. Then
untouched T cells from the same donor were isolated and stained
with CFSE (5 μM CFSE/DMSO for 10 min at 37◦C, before the
staining reaction was stopped with ice cold medium/10% FCS).
CFSE-stained cells were activated with CD3/CD28-beads and
co-cultured with washed Tregs, Th17 cells, or PMT-generated
T cells (ratio 1:1). After 5 days of co-culture the ﬂuorescent
signal of the CFSE-labeled cells was quantiﬁed on the FACSCanto
(FITC channel). Histogram overlays were performed using the
Weasel.jar software.
Statistics
Statistical signiﬁcance was assessed using Prism6 software using
a two-sided ANOVA multiple comparison test with ∗p ≤ 0.05,
∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, ∗∗∗∗p ≤ 0.0001.
RESULTS
PMT Augments CD3/CD28-activated Th
Cell Proliferation
Our investigation aimed to identify whether Th cell
diﬀerentiation is targeted by the bacterial toxin PMT. In
the experiments, we treated blood-derived CD4-positive T
cells with anti-CD3- and anti-CD28-coupled beads to achieve
full activation of the cells in the absence of an APC. This
activation induces a network of downstream signaling pathways
that eventually leads to cell proliferation and subsequently,
depending on the cytokine environment, to diﬀerentiation into
speciﬁc eﬀector cells (Coquet et al., 2015). To investigate whether
PMT is toxic for T cells, we initially checked its inﬂuence on
the viability of CD3/CD28-activated T cells. To test this, we
quantiﬁed the amount of cellular ATP in an assay where the
ATP is used to generate a luminescence signal. Figure 1A
shows that the ATP level of CD3/CD28-activated cells was
increased considerably after 7 days in culture which conﬁrmed
the activation of cells and suggested an increase of the cell
number. The additional stimulation with PMT remarkably
enhanced lymphocyte viability. A PMT mutant, where a point
mutation within the catalytic domain renders the toxin inactive,
as well as heat-inactivated PMT did not alter the CD3/CD28-
mediated activation. Therefore we concluded that the observed
eﬀect is mediated by the enzymatic function of PMT and
that a potential endotoxin contamination can be excluded. To
investigate whether the increase in cell viability is due to an
increase in Th cell proliferation, stainings with ﬂuorescent CFSE
that binds covalently to proteins and other amino groups were
performed. During cell division the ﬂuorescent dye is passed
on to the dividing cells and thus the ﬂuorescence intensity
decreases with each division. Figure 1B shows that PMT
treatment leads to an enhanced number of cells that underwent
cell division. Additionally, the PMT-stimulated cells divided
more frequently than the CD3/CD28-activated cells (mean
ﬂuorescence of 4222 for PMT-treated cells vs. 6562 for untreated
cells).
The proliferation rate of T cells can be altered by various
signals. IL-2 is a potent growth factor that mediates cell cycle
entry, increases survival of dividing cells and also guides the
diﬀerentiation of T cells (Oppenheim, 2007). To investigate
whether PMT enhances T cell proliferation through an increased
secretion of IL-2, we quantiﬁed the production of this cytokine
by ELISA. The kinetics revealed that the IL-2 concentration of
CD3/CD28-activated cells increased from day one to day seven,
as expected. Addition of PMT eﬀectively enhanced the release
of the cytokine compared to CD3/CD28-activated cells, at least
during the ﬁrst 3 days of culture, which might be a reason for the
observed increase in proliferation (Figure 1C).
PMT Mediates Cell Cycle Progression
and Survival of Th Cells
In the following experiments we aimed to determine the inﬂuence
of PMT on cellular proliferation in more detail. Therefore we
analyzed the cell cycle stages of Th cells. The cell cycle can
be divided into four major phases. In the G0 phase the cell
rests. When it enters G1 phase it increases its size and produces
proteins as well as other cellular components. DNA replication
takes place in the synthesis (S) phase, which is followed by the
preparation (G2 phase) for cell division. Finally the division of
the nucleus (M Phase,mitosis) and the formation of two daughter
cells (cytokinesis) occur. An eﬀective T cell cycle run requires
TCR activation to trigger transition from the G0 to G1 phase
and subsequently activation of the IL-2 receptor, which mediates
the entry into S phase (Cantrell and Smith, 1984; Meuer et al.,
1984). To examine the eﬀect of the toxin on the cell cycle,
we quantiﬁed the DNA content of the cells. Cells were stained
with propidium iodide (PI) to determine the amount of cellular
DNA by FACS. As a control for G2/M, cells were treated with
nocodazole, a substance that interferes with the polymerization
of microtubules and thus inhibits division into daughter cells so
that nocodazole-treated cells contain the maximum amount of
DNA during cell cycle. As a control for G0/1 phase and therefore
the minimal amount of DNA, cells were treated with CT from
Vibrio cholerae which is known to induce cell cycle arrest in the
early G1 phase (Zheng et al., 2014). Figures 2A,B show that non-
activated Th cells paused in G1/0 phase. CD3/CD28-activation
stimulated the increase of DNA per cell which is characteristic
for the S phase of the cycle. Stimulation of CD3/CD28-activated
cells with PMT induced a further increase of the PI signal
and revealed a population with a DNA amount that is typical
for the G2/M phase. We therefore conclude that the toxin
mediates progression of the cell cycle and DNA synthesis.
To link this to molecules known to be involved in cell cycle
progression, we checked the impact of PMT on the expression
and activation level of cyclin-dependent kinases (CDKs), the
regulatory cyclins and CDK inhibitors (Figure 2C). CDK activity
is regulated by its phosphorylation status, association with cyclins
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FIGURE 1 | Pasteurella multocida toxin (PMT) stimulates CD3/CD28-activated T cell proliferation. (A) CD4-positive T cells were activated with
anti-CD3/CD28-coated beads (T Cell Activation/Expansion Kit, Miltenyi) and stimulated for 5 days with 1 nM PMT wild-type (wt), heat-inactivated PMT (dT), or a
catalytically inactive mutant (PMTC1165S). Viability of cells was determined by quantification of ATP using the CellTiter-Glo R© Luminescent Cell Viability Assay
(Promega). Shown is the mean ± SD, n = 6 (six donors, each experiment performed in duplicates). (B) Th cells were CFSE-labeled, CD3/CD28-activated and
stimulated for 5 days with 1 nM PMT. Proliferation cycles were assayed by measuring the decreasing fluorescence by flow cytometry. The mean fluorescence and
percentages refer to the gated (dividing) cells. Shown is the result of one representative donor out of three. (C) CD3/CD28-activated Th cells were stimulated with
PMT for 1, 3, or 5 days. IL-2 ELISAs were performed (mean ± SD, n = 4; four donors, each experiment performed in duplicates). Statistical analysis was performed
using two-sided ANOVA for multiple comparisons (∗∗∗p ≤ 0.001).
and binding of inhibitory molecules. Entry into S phase is
mediated by CDK6/cyclin D and CDK4/cyclin D complexes and
their activation requires the degradation of the inhibitor p27.
The active complex then enables transcription factors to activate
G1/S-phase gene expression (Bendris et al., 2015). The performed
western blot analysis showed that PMT indeed mediates an
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FIGURE 2 | PMT stimulates cell cycle progression. (A) CD4-positive T cells were cultured overnight without activation to synchronize cells in G0 phase. Then
cells were CD3/CD28-activated and stimulated with PMT for 24 h. As controls, cells were treated with 100 ng/ml CT (G0/1 phase) or 100 ng/ml nocodazole (G2
phase). Nuclei were stained with propidium iodide (PI) and intensity of the PI signal was quantified by flow cytometry (x-axis: PE-A, y-axis: PE-W). (B) Quantification
of the percentage of cells in G1/0, S and G2/M phase (mean ± SD, n = 3). (C) Cell lysates were used for western blot analysis with specific antibodies against cyclin
B, pCDC2 (CDK1), cyclin D1, cyclin E, CDK4, or p27. Equal loading was verified by detection of actin (whole cell lysates) or B23 (nuclear extracts). The results were
corroborated with two more donors. (D,E) T cells were stimulated with PMT for 1, 3, or 5 days, lysed and the activation of caspase-8 (D) or caspases 3 and 7 (E)
was measured with a Caspase-8Glo R© Assay or a Caspase 3/7-Glo R© Assay, respectively (Promega). Shown is the mean ± SD, n = 3 donors. Statistical analysis for
this figure (B,D,E) was performed using two-sided ANOVA for multiple comparisons (∗∗p ≤ 0.01; ∗∗∗p ≤ 0.001; ∗∗∗∗p ≤ 0.0001).
increased degradation of p27, an increase in cyclin E expression
and additionally induces a stronger accumulation of CDK4,
CDK6, and cyclin D in the nucleus than CD3/CD28. Furthermore
PMT increases the expression of cyclin E which in complex with
CDK2 promotes degradation of p27 (Bendris et al., 2015). Hence,
toxin treatment seems to promote the entry into the S phase of the
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cell cycle. The entry of all eukaryotic cells into mitosis is regulated
by activation of CDK1 (cdc2) at the G2/M transition. A critical
regulatory step is the dephosphorylation of CDK1 at Thr14 and
Tyr15 (Atherton-Fessler et al., 1994) and the phosphorylation-
regulated translocation of cyclin B1 to the nucleus. Our results
show reproducibly that PMT slightly enhances the translocation
of cyclin B to the nucleus and a dephosphorylation of Tyr15 of
CDK1. These results corroborate earlier ﬁndings reporting the
upregulation of cell cycle progression by PMT using a ﬁbroblast
cell line (Wilson et al., 2000).
From our previous work in HEK 293 cells we knew that PMT
is not only able to trigger proliferation, but also protects cells from
staurosporine-induced apoptosis through the PI3K-dependent
phosphorylation of Akt and the constitutive expression of
the survival kinase Pim-1, respectively (Preuss et al., 2010).
Programmed cell death is an integral part of the immune
response, as the removal of T cells after clearance of the infection
restores immune cell homeostasis (Pinkoski and Green, 2005).
Taking this into consideration, the increased T cell number under
PMT treatment could additionally be caused by the inhibition
of apoptosis of activated T cells. To check this possibility, we
analyzed caspase-8 and caspase-3/7 activation as central markers
of the apoptotic response. The luminescence-based assays show
that the activity of caspase-8 (Figure 2D) and caspase-3 and -7
(Figure 2E) increased considerably after 5 days of CD3/CD28-
activation. Stimulation with PMT, however, kept the activity of
the death caspases at the basal level of freshly isolated, naïve
T cells. This supports our hypothesis that the toxin does not
only trigger proliferation but also inhibits apoptosis of receptor-
activated Th cells. In summary these data demonstrate that PMT
expands CD3/CD28-activated Th cells by triggering proliferation
and by suppressing apoptosis.
PMT Induces Foxp3 and RORγt-Positive
T Cells
As we had observed that PMT supports the CD3/CD28-
mediated proliferation of Th cells, we next aimed to investigate
whether the toxin also modulates the diﬀerentiation of naïve
T cells into speciﬁc T cell subtypes. T cell diﬀerentiation
is dependent on the cytokine environment. Downstream of
cytokine-induced receptor activation, STAT transcription factors
play a pivotal role in T cell diﬀerentiation through the induction
of subtype-speciﬁc genes. Hence our ﬁrst question addressed
the PMT-mediated phosphorylation and activation of STAT
family members. Western blot analysis of toxin-stimulated cells
(Figure 3A) shows a pronounced phosphorylation of STAT-3
in comparison to CD3/CD28-induced cells after 24 h of toxin
treatment. As expected, STAT-5 phosphorylation was induced
by CD3/CD28 activation, presumably via the production of
IL-2, but this activation level could still be enhanced by PMT
treatment. Phosphorylation of STAT-4 was not aﬀected by
antibody-activation and only slightly induced by PMT. Finally
STAT-6 phosphorylation could not be observed under antibody
or toxin conditions. As pSTAT-3 mediates diﬀerentiation of
Th17 cells and pSTAT-5 is important in Treg formation, we
generated these T cell subtypes in vitro and compared the STAT
activation level of cytokine-diﬀerentiated control cells with PMT-
treated cells. On day one, PMT treatment caused an intense
phosphorylation of both transcription factors, however, on day
seven only pSTAT-3 was detectable. Whereas fully diﬀerentiated
(day 7) Tregs contained activated STAT-5 and only basal level
of phosphorylated STAT-3, Th17 cells showed high STAT-3 but
no STAT-5 activation. The data show that PMT-stimulated T
cells display the same STAT activation pattern like Th17 cells
(Figure 3B). When we analyzed the master transcription factors
of subtype development after 24 h of treatment (Figure 3C), we
found that in line with our previous results, toxin-stimulated
CD4-positive cells contained higher copy numbers of RORC
(STAT-3 target) and FOXP3 (STAT-5 target) mRNA compared
to GATA3 (induced by STAT-6) and TBET (induced by STAT-4).
This was conﬁrmed on the protein level by intracellular FACS
analysis (Figure 3D) where high expression of Foxp3 and RORγt
could be found in cells that had been treated with PMT for
7 days. The CD3/CD28-activated population already contained
a considerable amount of Foxp3, which is probably due to IL-
2-mediated STAT-5 activation. These data raised the question
whether PMT stimulates the diﬀerentiation of two diﬀerent T
cell subtypes or whether one subtype with two simultaneously
expressed master transcription factors was produced. Double
stainings for Foxp3 and RORγt (Figure 3E) revealed that the
antibody-activated T cell population did not contain any double
positive cells. In contrast to that the PMT-treated population
contained around 30% RORγt-positive, 20% Foxp3-positive and
almost 46% double positive T cells, even after 10 days of culture.
PMT Mediates Differentiation of an
Inflammatory T Cell Subtype
Our results pointed to two diﬀerent sets of T cell responses
toward the bacterial toxin. Th17 cells have an autoinﬂammatory
potential and support the immune response against extracellular
bacteria, whereas Foxp3-positive Tregs have a suppressive role
and protect the organism from autoimmunity. The diﬀerent
eﬀector T cell types are ultimately deﬁned by the cytokines that
they release and by their function. Therefore we investigated
which cytokines are actually released from PMT-stimulated cells
and whether they support or suppress a T cell-driven immune
response. ELISA analysis revealed that PMT-modulated cells
release high amounts of IL-17A that is almost comparable to
that of Th17 cells (Figure 4A). However, these cells produced
nearly no immunosuppressive IL-10 (Figure 4B). FACS data
corroborated these ﬁndings and additionally showed that there
is no defect in the release of cytokines, but that IL-10 is
hardly expressed by these lymphocytes (Figure 4C). Some of
the CD3/CD28-activated T cells produced IL-10 (Figures 4B,C),
which conﬁrmed the diﬀerentiation of a few functional Foxp3-
positive cells. To investigate whether the PMT-generated T cell
subtype would rather have an activated or suppressive phenotype,
we measured the ability of PMT-modulated T cells to increase
or inhibit proliferation of CD3/CD28-activated CFSE-labeled
CD4-positive T cells. Our data show that the CFSE signal
of CD4-positive responder cells co-cultured with the PMT-
diﬀerentiated eﬀector subtype was lower than the signal obtained
by CD3/CD28-activated responders. Additionally, the inﬂuence
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FIGURE 3 | Continued
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FIGURE 3 | Continued
PMT induces Foxp3 and RORγt-positive T cells. CD3/CD28-activated T
cells were stimulated with PMT overnight or for 7 days, respectively. (A) Whole
cell lysates were produced and antibodies against p(Y705)STAT-3, STAT-3,
p(Y694)STAT-5, STAT-5, p(Y641)STAT-6, STAT-6, and p(Y693)STAT-4, STAT-4
were used for immunoblotting. Equal loading of protein was verified by actin
detection. (B) As a positive control, T cells were treated with 100 ng/ml IL-1β,
IL-23, IL-6, TGF-β (Th17 cells), or 100 ng/ml IL-2 and rapamycin (Tregs).
(C) Quantitative RT-PCRs were performed using SYBR Green and sequence
specific primers for FOXP3, TBET, GATA3, and RORC. Results were
normalized against the housekeeping gene actin. Shown is the mean of
induction compared to non-activated cells. SD, n = 2 donors, experiment
performed in duplicates. Statistical analysis was performed using two-sided
ANOVA for multiple comparisons (∗p ≤ 0.05). (D) Intracellular FACS analysis.
Fixed and permeabilized cells were stained with anti-CD4-APC, purified
anti-Foxp3 or anti-RORγt and FITC-/PE-labeled secondary antibodies.
(E) Intracellular double stain of Foxp3 or RORγt of cells on day ten. Data
shown in (A,C,D) are representative for three, and (E) for two experiments.
of PMT eﬀector cells on proliferation was similar to the impact of
Th17 cells. In contrast to this, Tregs showed an inhibitory impact
on T cell proliferation (Figure 4D). This experiment suggests that
the toxin modulates lineage decision of CD3/CD28-activated T
helper cells toward an inﬂammatory subtype.
DISCUSSION
The relationship between the host and microbial pathogens can
be quite complex. On the one hand the higher organism uses a
highly specialized immune system for the detection and control
of invading microorganisms, whereas pathogens have developed
various strategies to avoid their recognition and elimination. The
host’s innate immune system can sense foreign structures through
PRRs. In consequence of this recognition, pathogen-induced
phagocytosis and presentation onMHC takes place. Presentation
of the antigens to the TCR and the resulting association of CD3
with the TCR-peptide-MHC complex transmits the activation
signal to intracellular molecules, which trigger a cascade of
biochemical events that result in the expansion of antigen-
speciﬁc T lymphocytes. In addition, the diﬀerentiation into
eﬀector types is crucial for the course of the immune response.
Depending on the microbe and the activated PRRs, a speciﬁc
set of cytokines is produced by the APC, which mediates the
diﬀerentiation of appropriate eﬀector types. The plasticity of Th
cell diﬀerentiation during infection allows the development of
pathogen-speciﬁc eﬀector T cells. However, also the invading
microorganism may proﬁt from this plasticity by directing the
diﬀerentiation to an ineﬀective or a suppressive eﬀector type.
One example for such a manipulation has been described for
Chlamydiamuridarum. Chlamydia-infected APCs aremodulated
in terms of the phenotype, cytokine secretion proﬁle and antigen
presentation. This eventually shifts the immune response from
a protective Th1 to a non-protective Th2 response (Kaiko et al.,
2008). Also extracellular bacteria such as Staphylococcus aureus
and Streptococcus pyogenes disturb the balance between activation
and inhibition of immune cells that protects the host from an
over-reaction and re-establishes homeostasis after clearing the
infection. Superantigens (SAgs) produced by these bacteria can
activate up to 20% of all T cells in an individual, mediate a vast
T cell expansion and induce a strong cytokine storm that causes
serious harm to the host. Eventually, the majority of activated T
cells die and the remaining cells will be anergic or even induce
SAg-speciﬁc Treg-mediated tolerance to the microbe (Papiernik,
2001).
An excellent target to modulate the diﬀerentiation toward
an ineﬀective T cell subtype are STAT transcription factors
that transmit the cytokine-encoded diﬀerentiation signal. PMT
activates the JAK-STAT pathway very eﬃciently in many types
of cells (Kubatzky et al., 2013) and we found that the toxin also
induces STAT activity in human T cells. After 1 day of PMT
stimulation, the phosphorylation of both, STAT-3 and STAT-
5 was very pronounced, whereas after 7 days of stimulation
only phosphorylation of STAT-3 was detectable. Compatible with
these results, RT-PCRs revealed a high expression of STAT-5-
dependent FOXP3 and STAT-3-promoted RORC in PMT-treated
cells. This suggested that diﬀerentiation of Tregs and Th17
cells had taken place. Although the parallel development of two
opposing subtypes appears paradox at ﬁrst glance, it has been
hypothesized that the interplay between iTregs and Th17 cells
actually ﬁne-tunes the activation to prevent hyperactivation and
to facilitate the return to the steady state. This is supported by
the fact that the development of these two subtypes is closely
connected. Both subtypes need TGF-β for diﬀerentiation and
the ﬁnal direction of diﬀerentiation is induced by additional
cytokines. TGF-β, in cooperation with IL-2-signaling, promotes
STAT-5 activation and induction and maintenance of FOXP3
via the induction of the Smad pathway. Nevertheless, TGF-β
also mediates the maintenance of a functional IL-6 receptor
on activated T cells. Under inﬂammatory conditions, with high
concentrations of IL-6, TGF-β enables IL-6/STAT-3 signaling
and eventually the diﬀerentiation of Th17 cells (Lee et al., 2009).
The host’s beneﬁt from a high plasticity of Treg and Th17
cells is probably a fast reaction to the course of an infection.
After the initial recognition of the pathogen, the inﬂammatory
conditions change from the tolerogenic phenotype of nTregs
toward the response-activating Th17 cells. In the process of
clearance the cells are able to transdiﬀerentiate again into iTregs
to protect the body from hyperactivation (Gagliani et al., 2015).
In consideration of this close connection of Th17 cells and Tregs
and the complexity of the cytokine environment during infection
it is not surprising that naïve, TGF-β-activated T cells can co-
express RORγt and Foxp3. Our experiments show that after
1 week of culture several CD3/CD28-activated T cells are Foxp3
positive. This is probably due to the CD28-triggered and IL-2
mediated promotion of Foxp3 expression (Burchill et al., 2007;
Guo et al., 2008) and may be due to an increased survival of
nTregs (Weiss et al., 2011), (Figure 3D). Interestingly, 45% of
the PMT-stimulated activated T lymphocytes are positive for
both transcription factors. This could be caused by the strong
activation of STAT-3 and STAT-5 during the ﬁrst hours of
stimulation. Furthermore it suggests that the observed toxin-
mediated protection from apoptosis expands primarily Foxp3-
positive cells, which later additionally express RORγt. The
parallel production of RORγt and Foxp3 can lead to the
Frontiers in Microbiology | www.frontiersin.org 9 November 2015 | Volume 6 | Article 1273
Hildebrand et al. PMT Triggers Th17 Differentiation
FIGURE 4 | PMT mediates a Th17 phenotype. CD3/CD28-activated Th cells were stimulated with PMT for the indicated time points. In (A) IL-17A and (B) IL-10
ELISAs were performed (mean ± SD, n = 3). Statistical significance of the produced cytokine was compared to the value obtained on day 0 using two-sided ANOVA
for multiple comparisons (∗∗∗p ≤ 0.001; ∗∗∗∗p ≤ 0.0001). (C) For intracellular FACS analysis, fixed and permeabilized cells were double-stained with anti-CD4-APC
and purified anti-IL-10 or anti-IL-17 antibodies and the according FITC-/PE-labeled secondary antibodies. (D) Th cells were stimulated with PMT for 7 days. These
PMT-generated T cells were then co-cultured with freshly isolated, CFSE-labeled Th cells (ratio 1:1) from the same donor. The fluorescent signal of the FITC-positive
cells was quantified on day one and on day five of co-culture. Data shown in (C,D) are representative for three experiments (three donors).
induction of both IL-10 and IL-17 or just one of them (McGeachy
et al., 2007; Ichiyama et al., 2008; Zhou et al., 2008) and Foxp3
can directly bind to RORγt and prevent its action. Only the
additional stimulation with inﬂammatory cytokines such as IL-6
relieves Foxp3-mediated inhibition through a STAT-3-dependent
suppression of FOXP3 expression (Yao et al., 2007), and
promotes diﬀerentiation of Th17 eﬀector cells (Ichiyama et al.,
2008; Zhou et al., 2008). Our experiments indicate that the release
of IL-17 increases from day one to day seven of PMT stimulation
whereas the IL-10 concentration did not. This suggests that in
Frontiers in Microbiology | www.frontiersin.org 10 November 2015 | Volume 6 | Article 1273
Hildebrand et al. PMT Triggers Th17 Differentiation
the beginning of PMT-stimulation the activation of STAT-3 and
STAT-5 mediates the development of some IL-17 releasing Th17-
cells, some IL-10 releasing Tregs, and some RORγt, Foxp3 double
positive cells, which probably do not produce IL-17 due to an
inhibitory interaction. At later time points, when only STAT-3 but
no STAT-5 activation is observable, RORγt is released from Foxp3
inhibition and eﬀectively induces IL-17 expression. An additional
explanation for the low IL-10 production of toxin-treated cells
could be the expression of the kinase Pim-1.While the expression
of Pim-1 is inhibited by TCR activation, inﬂammatory conditions
with high level of IL-6 lead to the induction of Pim-1 in human
Tregs (Li et al., 2014). The kinase then phosphorylates Foxp3 at
serine 422, which inhibits Foxp3 chromatin binding activity and
eventually inhibits IL-10 production. Interestingly, our studies in
HEK 293 cells show that PMT is a much more potent inducer
of Pim-1 than IL-6 (Hildebrand et al., 2010). Therefore PMT
stimulation could overcome the TCR-mediated inhibition of
Pim-1 in the Foxp3-positive cells and the following mediated
phosphorylation would suppress IL-10 production.
An interesting connection between Th17 cells and the
bacterium is the interaction between the bone system and the
immune system. IL-17 is involved in the excessive inﬂammation
and activation of osteoclasts that strongly contributes to bone
destruction associated with rheumatoid arthritis (Lubberts,
2015). Here, Th17 cells trigger the expression of receptor
activator of nuclear factor-κB ligand (RANKL) in synovial cells,
which then, in cooperation with other inﬂammatory cytokines,
stimulate the diﬀerentiation and activation of monocytes into
osteoclasts (Sato et al., 2006). PMT is known to be a mitogen for
osteoclasts (Martineau-Doize et al., 1993; Jutras and Martineau-
Doize, 1996) and pigs infected with P. multocida suﬀer from
atrophic rhinitis, a pathologic condition characterized by PMT-
stimulated osteoclastic bone resorption at the nasal turbinates
and an inﬂammation of the nasal mucosa (Wilkie et al.,
2012). We have previously shown that the PMT-triggered
diﬀerentiation of bone marrow-derived mouse macrophages into
osteoclasts is strongly dependent on cytokines released by B
cells (Hildebrand et al., 2011). Cytokines produced by Th17-
cells could additionally support the PMT-mediated osteoclast
formation and the destruction of bone and thereby support the
pathogenesis of toxigenic P. multocida strains. Nevertheless, the
direction toward a Th17-mediated response is the normal course
of an immune response against pulmonary and gastrointestinal
pathogens like P.multocida (Garrido-Mesa et al., 2013). However,
it has been suggested that pathogens that trigger a persistent
Th17 response because they have not been not suﬃciently cleared
through the host’s immune system, may be more beneﬁcial
for the microorganism than the host (van de Veerdonk et al.,
2009).
In summary, we show that the bacterial toxin PMT enhances
the proliferation and survival of CD3/CD28-activated Th cells
and that the toxin manipulates the diﬀerentiation toward a Th17-
subtype through the activation of STAT transcription factors.
This once more illustrates how bacteria are able to target the
high plasticity of T cell subtypes to reinforce their pathogenicity
and possibly to gain an advantage in terms of survival and
reproduction.
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